GLP-1 Therapy: What to Expect in the First 90 Days

The first 90 days of a GLP-1 protocol follow a general arc: low starting doses that titrate upward, appetite changes many people notice within the first few weeks, a common early period of gastrointestinal adjustment, and regular physician check-ins that guide the pace. Individual variation is the rule, not the exception.

What follows is a general timeline, not a prediction for you specifically. Everyone starts from a different place and responds differently. Use this to understand the shape of the process, then rely on your check-ins with Dr. Jamie Luria, MD, for what applies to your case.

Weeks 1 to 4: starting low and settling in

The protocol begins at a low dose on purpose. A GLP-1 receptor agonist mimics a gut hormone that quiets appetite and slows how quickly the stomach empties, and your body needs time to adjust to that signal. Starting low is the main way early side effects are kept manageable.

In these first weeks, some people already notice a difference: hunger arrives less insistently, meals feel satisfying sooner, and the background preoccupation with food, often called food noise, begins to quiet. Others feel little at the starting dose and notice more once titration begins. Both are normal.

This is also when gastrointestinal adjustment is most common. Mild nausea, reduced appetite, constipation, or looser stools are the effects people report most, and they are usually most noticeable early or just after a dose change. For most people these ease as the body adapts.

Weeks 4 to 8: titration and the appetite shift

Titration means increasing the dose gradually over time. During this middle stretch, Dr. Luria may step your dose up according to a schedule set to your response. The pace is deliberate: moving up too fast tends to trade progress for discomfort, so holding at a dose is a legitimate choice, not a delay.

By now, most people who are going to respond notice the appetite change clearly. Portions fall naturally rather than through willpower. Cravings for specific foods may fade. Weight change, if it is happening, is usually gradual rather than dramatic, and it is rarely a straight line.

The scale is the noisiest signal in the first 90 days. Appetite, portion sizes, and how food occupies your attention often tell you more about whether the protocol is working.

Weeks 8 to 12: finding a rhythm

By the third month, many people have reached a dose that fits and settled into a steadier pattern. Early GI effects have often faded. Plateaus are common and expected here; weight rarely moves in even weekly increments, and a flat stretch is not a failure. It is one of the main things check-ins exist to interpret.

This is also where the difference between a quick result and a durable one starts to show. The medication makes the behavioral work more achievable by quieting appetite, but it is the habits built during this window that carry results beyond it.

Managing common GI effects

A few general practices tend to help with early gastrointestinal effects, and Dr. Luria can tailor them to you. Eating smaller portions makes sense when the stomach is emptying more slowly. Prioritizing protein and fluids supports you when overall intake drops. Easing back on very rich or greasy meals often reduces nausea. Constipation usually responds to fluids, fiber, and movement.

The most important practice is messaging Dr. Luria about anything persistent, severe, or simply concerning. Slowing titration or holding a dose is a normal adjustment, and it is far better to raise an issue early than to push through it.

Why monitoring matters

A physician-supervised model is not a formality. Your dose, your pace, and your response are individual, and someone accountable should be watching them. Before the protocol begins, Dr. Luria reviews your full medical history, including screening for histories that make GLP-1 therapy inappropriate or warrant caution, such as a personal or family history of medullary thyroid carcinoma, MEN2, or pregnancy. That is clinical judgment applied to your record.

Through the first 90 days, regular check-ins are where titration decisions get made, side effects get addressed, plateaus get interpreted, and expectations stay honest. Keeping that line of communication open is one of the strongest predictors of a good experience.

The foundation underneath the protocol

A GLP-1 protocol is a tool, not the whole plan, and the first 90 days are the best time to build the habits that outlast it.

Three matter most. Adequate protein protects lean mass while your weight changes and helps you feel satisfied on smaller portions. Resistance training preserves muscle, which matters for how you look, feel, and maintain results. Consistent sleep shapes appetite hormones in its own right and makes everything else easier. When appetite is quieter, these habits are more achievable than they have probably ever been. That window is the real opportunity of the first 90 days.

Nothing here is a promise of results. Responses vary, outcomes are individual and never guaranteed, and the honest measure of success is not a number by day 90 but whether you have built something you can sustain, with Dr. Luria guiding the way.

This article is educational and does not constitute medical advice, and reading it does not create a physician-patient relationship. Decisions about peptide therapy should be made in consultation with a licensed physician who has reviewed your individual health history. Compounded GLP-1 medications are prepared by Blue Atlas Pharmacy, a licensed 503A compounding pharmacy, under the prescription of Dr. Jamie Luria, MD. Compounded medications are not FDA-approved for safety, efficacy, or quality.